Alpha 2.0
Login Register
» Articles » PMID: 2652604

Pre-operative Interleukin 2 and Interleukin 2 Receptor Levels May Predict Subsequent Renal Allograft Rejection

Overview
Journal Transplant Proc
Specialty General Surgery
Date 1989 Feb 1
PMID 2652604
Citations 2
Authors
A J Cornaby
M A Simpson
P N Madras
R A Dempsey
G H Clowes
A P Monaco
Affiliations
Soon will be listed here.
Citing Articles

The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024.

Sehgal A, Tauber P, Stieger R, Kratzer B, Pickl W Int Arch Allergy Immunol. 2023; 185(3):286-300.

PMID: 38086339 PMC: 10911178. DOI: 10.1159/000533677.

Systemic (serum) soluble interleukin-2 receptor levels in corneal transplant recipients.

Foster C, Wu H, Merchant A Doc Ophthalmol. 1993; 83(1):83-9.

PMID: 8334924 DOI: 10.1007/BF01203574.